Preliminary safety, antitumor activity and pharmacodynamics results of HIT-IT MEDI1191 (mRNA IL-12) in patients with advanced solid tumours and superficial lesions Meeting Abstract


Authors: Hamid, O.; Hellman, M.; Carneiro, B.; Marron, T.; Subbiah, V.; Mehmi, I.; Eyles, J.; Dubois, V.; Ridgway, B.; Hamid, O.; Hernandez, A. G.
Abstract Title: Preliminary safety, antitumor activity and pharmacodynamics results of HIT-IT MEDI1191 (mRNA IL-12) in patients with advanced solid tumours and superficial lesions
Meeting Title: ESMO Targeted Anticancer Therapies Virtual Congress (TAT) 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 1
Meeting Dates: 2021 Mar 1-2
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-03-01
Start Page: S9
Language: English
ACCESSION: WOS:000630459000020
DOI: 10.1016/j.annonc.2021.01.033
PROVIDER: wos
Notes: Meeting Abstract: 19O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    412 Hellmann